HCA Continues To Drive Organic Growth
Alpha Gen Capital
Alpha Gen Capital
HCA Holdings: A Low-Risk Play On Continued Reform Growth
Alpha Gen Capital
Alpha Gen Capital
Dec. 18, 2015, 12:18 PM
- Biogen (BIIB +0.2%) initiated with Overweight rating and $344 (16% upside) price target by Atlantic Equities.
- CVS Health (CVS -0.1%) initiated with Overweight rating and $110 (16% upside) price target by Barclays.
- Clovis Oncology (CLVS +0.9%) initiated with Buy rating and $50 (48% upside) price target by Janney.
- Relypsa (RLYP +2.6%) initiated with Buy rating and $63 (123% upside) price target by H.C. Wainwright.
- HCA Holdings (HCA -0.2%) initiated with Outperform rating and $75 (16% upside) price target; LifePoint Health (LPNT +0.4%) with an Outperform rating and $79 (13% upside) price target; Tenet Healthcare (THC +1.2%) with a Neutral rating and $33 (18% upside) price target and Universal Health Services (UHS +0.4%) with a Neutral rating and $129 (11% upside) price target by Credit Suisse.
- Amgen (AMGN -0.1%) upgraded to Overweight from Equal Weight by Morgan Stanley. Price target raised to $193 (20% upside) from $160.
- Valeant Pharmaceuticals (VRX -1.8%) downgraded to Neutral from Buy by Mizuho Securities. Price target raised to $130 (19% upside) from $111.
Dec. 3, 2015, 9:38 AM
- HCA Holdings (HCA +0.6%) commences a public offering of $500M aggregate principal amount of 5.875% senior notes due 2026. The notes will trade interchangeably with the $1.0B aggregate principal amount of 5.875% senior notes due 2026 issued by the company on November 13.
- Net proceeds will be used for general corporate purposes.
Nov. 23, 2015, 2:47 PM
- Goldman Sachs' Hedge Fund VIP list of the 50 most-heavily-owned stocks have trailed the S&P 500 by about 500 basis points (down 2% vs. the S&P's 3% gain) year-to-date, including 720 basis points of underperformance since the start of October (down about 8% vs. down about 1%).
- Call it the Valeant effect: Health-care stocks have accounted for about 70% of the year-to-date 2% decline.
- Based on the most recent filing, hedge funds are bailing on some of their poorer performers, including Valeant (NYSE:VRX), HCA Holdings (NYSE:HCA), Endo (NASDAQ:ENDP), Ally Financial (NYSE:ALLY), and NorthStar Realty (NYSE:NRF), and have instead placed bets on Baidu (NASDAQ:BIDU), Mylan (NASDAQ:MYL), MGM Resorts (NYSE:MGM), and GE.
- After the shakeup, the top five hedge fund hotels: Allergan (NYSE:AGN), Facebook (NASDAQ:FB), Alphabet (GOOG, GOOGL), Time Warner Cable (NYSE:TWC), and Amazon (NASDAQ:AMZN).
Oct. 27, 2015, 10:29 AM
- HCA Holdings (HCA +1.1%) Q3 results: Revenues: $9,856M (+6.9%); Salaries and Benefits: $4,619M (+9.7%); Supplies: $1,644M (+6.8%); Other Operating Expenes: $1,796M (+6.4); Adjusted EBITDA: $1,815M (-0.7%); Net Income: $449M (-13.3%); EPS: $1.05 (-9.5%); Quick Assets: $588M (+3.9%).
- Reported Admissions: 466,400 (+3.8%); Equivalent Admissions: 787,300 (+4.8%); Revenue per Equivalent Admission: 12,517 (+2.0%); Inpatient Surgery Cases: 134,000 (+2.1%); Outpatient Surgery Cases: 226,400 (+1.7%); ER Visits: 2,023,100 (+7.2%).
- 2015 Guidance: Non-GAAP EBITDA: ~ $7.8B; Non-GAAP EPS: $5.20 - 5.25.
Oct. 27, 2015, 8:32 AM
- HCA Holdings (NYSE:HCA): Q3 EPS of $1.17 misses by $0.03.
- Revenue of $9.9B (+7.4% Y/Y) in-line.
Oct. 26, 2015, 5:30 PM
- AHGP, AIXG, AKS, AME, AMTD, ARG, ARLP, AVX, AXE, BABA, BAX, BEAV, BMY, BP, BTU, CMCSA, CMI, CNC, CNX, COH, CPLA, CRY, CVLT, CYNO, DD, ERJ, F, FBC, FCH, FDP, FMER, GLW, GPI, GRUB, HCA, HUN, ICLR, IIVI, IMGN, IPGP, IPI, IR, JBLU, LPT, LRN, LXK, MAS, MDC, MDSO, MGLN, MMC, MNI, MRK, MSM, NCI, NVS, ONE, PCAR, PCH, PCRX, PFE, POL, POR, QSR, RAI, RDN, SAVE, SCHN, SEE, SIR, SPG, SPR, ST, SUI, TMUS, TREX, TXT, UPS, UTHR, WAT, WDR, WM, WSO, WYN, YNDX
Oct. 22, 2015, 9:26 AM
- Community Health's (NYSE:CYH) failure to meet Q3 consensus has created softness for other hospital operators. Tenet Healthcare (NYSE:THC) is down 12% and (NYSE:HCA) is down 7% in premarket trading.
- Previously: Preliminary Q3 results sink Community Health; shares down 22% premaket (Oct. 22)
Oct. 22, 2015, 9:14 AM
Oct. 15, 2015, 9:13 AM
Oct. 14, 2015, 5:39 PM
Oct. 14, 2015, 4:37 PM
- HCA Holdings (NYSE:HCA): Q3 EPS of $1.17 misses by $0.05.
- Revenue of $9.86B (+6.9% Y/Y) beats by $10M.
- Shares -5%.
Sep. 16, 2015, 7:03 PM
- J.P. Morgan analysts warn that companies with large amounts of floating-rate debt - including Chesapeake Energy, Freeport McMoRan, Ford and GE - could be at risk if the Fed decides to raise interest rates.
- Companies with variable/floating-rate debt suffer a more immediate impact by a rate hike than companies with fixed-rate debt, the analysts say; variable-rate coupons typically reset quarterly, meaning that changes in the base rate flow through almost immediately to variable-rate borrowers, while fixed-rate borrowers do not see such an impact until they refinance or issue new debt.
- JPM lists 25 companies - not including financials - that have the “highest variable-rate debt as a percentage of market cap": FMC, NRG, FCX, AES, CVC, LVLT, PVH, CHK, FE, DVA, THC, OI, CNX, F, HCA, FOSL, RCL, JOY, GE, ADS, ALLE, HBI, GT, DNB, AN
Aug. 25, 2015, 5:35 PM
- investors should stick with "market darlings" - the 25 stocks that had performed the best during the six months before a market pullback - according to the analyst team at RBC.
- The firm notes that although many recent winners are leading the market lower, the extent of the underperformance is just 1%; it also says investing in the group following sharp market pullbacks is a winning strategy over the ensuing week, month and six months.
- RBC's 25 market darlings are AET, ALTR, AMZN, AIZ, CVC, CI, CAG, EA, EQIX, EXPE, GME, GOOGL, HAS, HCA, MNST, NFLX, NKE, PRGO, REGN, SBUX, TSO, TWC, TSS, UA, UHS
Aug. 5, 2015, 9:09 AM
- HCA Holdings (NYSE:HCA) Q2 results ($M): Net Revenues: 9,897 (+7.2%); Operating Expenses: 7,917 (+8.8%); Non-GAAP EBITDA: 2,008 (+0.4%); Quick Assets: 673 (+2.3%).
- Net Income: 507 (+5.0%); EPS: 1.18 (+10.3%); CF Ops: 1,057 (-15.4%).
- Admissions: 464,200 (+4.8%); Equivalent Admissions: 778,200 (+6.0%); Revenue per Equivalent Admission: 12,719 (+1.2%); Inpatient Surgery Cases: 131,800 (+2.4%); Outpatient Surgery Cases: 228,300 (+1.5%); ER Visits: 2,007,400 (+8.5%).
- 2015 Guidance: Net Revenues: $39B - 40B (unch); Non-GAAP EBITDA: $7.55B - 7.85B (unch but upper end of range); Non-GAAP EPS: $4.90 - 5.30 (unch); CAPEX: ~$2.5B (unch).
Aug. 5, 2015, 8:33 AM
- HCA Holdings (NYSE:HCA): Q2 EPS of $1.37 beats by $0.03.
- Revenue of $9.9B (+7.3% Y/Y) beats by $80M.
- Shares +1.06% PM.
Aug. 4, 2015, 5:30 PM
- AMSC, ANSS, ARIA, ARQL, ATHM, ATRO, AVA, AVT, BLT, CEQP, CHK, CLDT, CLH, CMLP, CONE, CRK, CRME, CSTE, CSTM, CTSH, D, DAVE, DISCA, DISH, DNOW, DNR, EE, ENBL, FI, GDP, GTN, HCA, HFC, HSC, ICE, INXN, KATE, KELYA, KERX, LDOS, LG, LINC, LIOX, LL, LPLA, MEMP, MSI, MSO, MWE, PCLN, PWR, RDC, RL, SALE, SBGI, SCMP, SE, SNAK, SODA, SPAR, SPB, SUP, TMHC, TWX, USAC, VC, VLP, VOYA, VSI, WCG, WD, WEN, WIX
HCA Holdings, Inc. owns and operates hospitals, freestanding surgery centers, diagnostic and imaging centers, radiation and oncology therapy centers, comprehensive rehabilitation and physical therapy centers and various other facilities. It provides services such medical specialties as internal... More
Country: United States
Other News & PR